Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8)
- PMID: 17689377
- DOI: 10.1016/j.drugpo.2007.01.014
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8)
Abstract
The introduction of potent anti-retroviral treatment (ART) has transformed HIV disease into a chronic condition with the prospect, for the patient, of strict adherence to effective but life-long treatments. Within this framework, a major issue that can negatively affect adherence is the side-effects of the treatment. To date, studies documenting how individuals HIV-infected through drug injection (IDUs) experience ART-related side effects are sparse. Longitudinal data collected from the APROCO-COPILOTE cohort have been used to compare the experience of ART-related side-effects who have been HIV-infected via injecting drug use and non-IDU patients. A 20-item list was used to collect self-reported side-effects over a 7-year follow up period. Of 922 patients, 15% were IDUs. At any given visit, IDUs reported a significantly higher number of side-effects and had approximately twice the risk of reporting any side effect than non-IDUs. Most commonly reported side-effects were dry skin, fatigue, vomiting, bone troubles, insomnia. After adjustment for social conditions, depressive symptoms, use of sleeping pills and time since HIV diagnosis, IDUs reported experiencing significantly more side-effects than non-IDUs. Whether or not this is related to sensitivity to pain or to other comorbidities is difficult to establish. Further research is needed to understand how substitution treatment can mediate the relationship between exposure to opioids and side-effects. Providing appropriate care to reduce side-effects, thereby increasing adherence to ART in this population, remains a major challenge especially in those countries scaling up ART. Incorporating symptom management and improving access to analgesic medications within a model of comprehensive care for HIV-infected IDUs, could reduce the impact of drug-related and HIV-related harms and induce better long-term treatment outcomes and quality of life.
Similar articles
-
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).Int J Drug Policy. 2007 Aug;18(4):262-70. doi: 10.1016/j.drugpo.2006.12.014. Epub 2007 Jan 26. Int J Drug Policy. 2007. PMID: 17689374 Review.
-
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.Addiction. 2008 Nov;103(11):1828-36. doi: 10.1111/j.1360-0443.2008.02323.x. Epub 2008 Sep 4. Addiction. 2008. PMID: 18778390
-
Health related quality of life among both current and former injection drug users who are HIV-infected.Drug Alcohol Depend. 2007 Jan 12;86(2-3):175-82. doi: 10.1016/j.drugalcdep.2006.06.012. Epub 2006 Aug 22. Drug Alcohol Depend. 2007. PMID: 16930864
-
Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment.Int J Drug Policy. 2007 Aug;18(4):319-25. doi: 10.1016/j.drugpo.2007.04.001. Epub 2007 Jun 21. Int J Drug Policy. 2007. PMID: 17689381
-
Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").Addiction. 2006 Sep;101(9):1246-53. doi: 10.1111/j.1360-0443.2006.01509.x. Addiction. 2006. PMID: 16911723 Review.
Cited by
-
Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy.AIDS Care. 2017 Apr;29(4):418-422. doi: 10.1080/09540121.2016.1220478. Epub 2016 Aug 18. AIDS Care. 2017. PMID: 27535297 Free PMC article.
-
Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapy.BMJ Open. 2012 Nov 23;2(6):e001155. doi: 10.1136/bmjopen-2012-001155. Print 2012. BMJ Open. 2012. PMID: 23180454 Free PMC article.
-
HIV-Related Stress and Life Chaos Mediate the Association Between Poverty and Medication Adherence Among People Living with HIV/AIDS.J Clin Psychol Med Settings. 2016 Dec;23(4):420-430. doi: 10.1007/s10880-016-9481-8. J Clin Psychol Med Settings. 2016. PMID: 27873055
-
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.Pain. 2012 Oct;153(10):1997-2008. doi: 10.1016/j.pain.2012.05.029. Epub 2012 Jul 5. Pain. 2012. PMID: 22770841 Free PMC article. Review.
-
Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework.J Behav Med. 2015 Aug;38(4):632-41. doi: 10.1007/s10865-015-9633-6. Epub 2015 Apr 3. J Behav Med. 2015. PMID: 25835435 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical